About the journal
JHEP Reports is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 4,110 USD. Declared review time at DOAJ: 33 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2589-5559
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,110 USD
- Articles in DOAJ
- 1477
- Declared review time
- 33 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/jhep-reports
Index listings
- DOAJ · 2019-09-09
- MEDLINE · 2026-01-01
- Indexing
- DOAJ · MEDLINE
- APC
- 4,110 USD
- Declared review time (DOAJ)
- 33 weeks
- Actual review time (measured)
- 152 days received→accepted — computed from PubMed (n=97)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1477
Most recent article
last month
Average review time (journal-declared via DOAJ)
33weeks
Works in OpenAlex
1583
Last recorded publication year
2026
h-index
74
i10-index
607
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2019-09-09
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 86%
- ORCID iDs in current deposits
- 82%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101761237
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
Show all subjects (50)
- Hepatitis B Virus Studies
- Hepatitis B Virus Studies
- Hepatitis C virus research
- Hepatitis C virus research
- Liver physiology and pathology
- Liver physiology and pathology
- Organ Transplantation Techniques and Outcomes
- Organ Transplantation Techniques and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Alcohol Consumption and Health Effects
- Alcohol Consumption and Health Effects
- Hepatitis Viruses Studies and Epidemiology
- Hepatitis Viruses Studies and Epidemiology
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Academic Publishing and Open Access
- Academic Publishing and Open Access
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- Gallbladder and Bile Duct Disorders
- Intellectual Property and Patents
- Copyright and Intellectual Property
- Intellectual Property and Patents
- Copyright and Intellectual Property
- Gallbladder and Bile Duct Disorders
- Pediatric Hepatobiliary Diseases and Treatments
- Pediatric Hepatobiliary Diseases and Treatments
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Drug-Induced Hepatotoxicity and Protection
- Drug-Induced Hepatotoxicity and Protection
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nutrition and Health in Aging
- Nutrition and Health in Aging
- Ferroptosis and cancer prognosis
- Diet, Metabolism, and Disease
Keywords (DOAJ)
- masld
- alcoholic liver disease
- liver cancer
- drug-induced liver injury
- genetic liver disease
- cirrhosis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ